Skip to content
The Singapore

From cancer to diabetes: Singapore biomedical startups expand into China to accelerate development of new treatments

From cancer to diabetes: Singapore biomedical startups expand into China to accelerate development of new treatments
Photo: CNA — Singapore · view original

Singapore startups are tapping China’s vast patient pool, hospital networks and manufacturing capabilities, but they must also navigate its evolving regulatory landscape.

Sources and story details